Clinicopathological characteristics and predictive markers of early gastric cancer with recurrence

Journal of Korean Medical Science

Volumn 24, Issue 6, 2009, Pages 1158-1164

  Kim, Jeong Won ^a,c   Hwang, Ilseon ^b,d   Kim, Mi Jung ^b   Jang, Se Jin ^b  

^a Seoul Veterans Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Hallym University   (South Korea)

^d Dongsan Medical Center   (South Korea)

Author keywords

Early gastric cancer; ErbB 2; Genes; Immunohistochemistry; Lymph node metastasis; Recurrence

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ANIMAL; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROTO ONCOGENE; RISK FACTOR; STOMACH TUMOR; TUMOR RECURRENCE;

ADULT; AGED; ANIMALS; FEMALE; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 75349110231     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.6.1158     Document Type: Article

References (30)

1. The Information Committee of the Korean Gastric Cancer Association. 2004 nationwide gastric cancer report in Korea. J Korean Gas-tric Cancer Assoc 2007; 7: 47-54.
2. Itoh H, Oohata Y, Nakamura K, Nagata T, Mibu R, Nakayama F. Complete ten-year postgastrectomy follow-up of early gastric cancer. Am J Surg 1989; 158: 14-6.
3. Matsusaka T, Kodama Y, Soejima K, Miyazaki M, Yoshimura K, Sugimachi K, Inokuchi K. Recurrence in early gastric cancer: a pathologic evaluation. Cancer 1980; 46: 168-72.
4. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. 1st ed. Tokyo: Kanehara Shuppan; 1995.
5. Kim WH, Park CK, Kim YB, Kim YW, Kim HG, Bae HI, Song KS, Chang HK, Chang HJ, Chae YS. A standardized pathology report for gastric cancer. Korean J Pathol 2005; 39: 106-13.
6. Lee HJ, Kim YH, Kim WH, Lee KU, Choe KJ, Kim JP, Yang HK. Clinicopathological analysis for recurrence of early gastric cancer. Jpn J Clin Oncol 2003; 33: 209-14.
7. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001; 10: 657-62.
8. Hofmann M, Stoss O, Shi D, Buttner R, van de Vijver M, Kim W, Ochiai A, Ruschoff J, Henkel T. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 2008; 52: 797-805.
9. Kimura M, Tsuda H, Morita D, Ichikura T, Ogata S, Aida S, Yoshizumi Y, Maehara T, Mochizuki H, Matsubara O. A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcino-ma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements. Virchows Arch 2004; 445: 255-62.
10. Ichiyoshi Y, Toda T, Minamisono Y, Nagasaki S, Yakeishi Y, Sugimachi K. Recurrence in early gastric cancer. Surgery 1990; 107: 489-95.
11. Shiozawa N, Kodama M, Chida T, Arakawa A, Tur G, Koyama K. Recurrent death among early gastric cancer patients: 20-years' experience. Hepatogastroenterology 1994; 41: 244-7.
12. Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer 1993; 72: 3174-8.
13. Wu B, Wu D, Wang M, Wang G. Recurrence in patients following curative resection of early gastric carcinoma. J Surg Oncol 2008; 98: 411-4.
14. Moertel CG. Multiple primary malignant neoplasms: Historical per-spectives. Cancer 1977; 40: 1786-92.
15. Folli S, Dente M, Dell'Amore D, Gaudio M, Nanni O, Saragoni L, Vio A. Early gastric cancer: prognostic factors in 223 patients. Br J Surg 1995; 82: 952-6.
16. Noguchi Y. Blood vessel invasion in gastric carcinoma. Surgery 1990; 107: 140-8.
17. Lawrence M, Shiu MH. Early gastric cancer. Twenty-eight-year experience. Ann Surg 1991; 213: 327-34.
18. Folli S, Morgagni P, Roviello F, De Manzoni G, Marrelli D, Saragoni L, Di Leo A, Gaudio M, Nanni O, Carli A, Cordiano C, Dell'Amore D, Vio A. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Iitalian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol 2001; 31: 495-9.
19. Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 2005; 92: 235-9.
20. Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology 2008; 52: 738-46.
21. Garcia I, Vizoso F, Martin A, Sanz L, Abdel-Lah O, Raigoso P, Garcia-Muniz JL. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol 2003; 10: 234-41.
22. Ross JS, McKenna BJ. The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 2001; 19: 554-68.
23. Ougolkov A, Yamashita K, Bilim V, Takahashi Y, Mai M, Minamoto T. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis. Int J Colorectal Dis 2003; 18: 160-6.
24. Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008; 19: 1523-9.
25. Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Yoo CH, Son BH, Cho EY, Chae SW, Kim EJ, Sohn JH, Ryu SH, Sepulveda AR. HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci 2006; 51: 1371-9.
26. Rhyu MG, Park WS, Meltzer SJ. Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 1994; 9: 29-32.
27. Wu MS, Lee CW, Shun CT, Wang HP, Lee WJ, Chang MC, Sheu JC, Lin JT. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer 2000; 27: 403-11.
28. Feng CW, Wang LD, Jiao LH, Liu B, Zheng S, Xie XJ. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: Correlation with clinical features. BMC Cancer 2002; 2: 8.
29. Pan W, Ishii H, Ebihara Y, Gobe G. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. J Surg Oncol 2003; 82: 104-10.
30. Takata K, Matsuzaki T, Tajika Y. Aquaporins: water channel proteins of the cell membrane. Prog Histochem Cytochem 2004; 39: 1-83.